Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Conatus Pharmaceuticals Inc. (CNAT)

1.3627 -0.027 (-1.96%)

12-18 09:57

Open:

1.4

Pre. Close:

1.39

High:

1.43

Low:

1.3

Volume:

67,330

Market Cap:

41M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.562 - 1.57

1.57 - 1.577

Low:

1.34 - 1.349

1.349 - 1.357

Close:

1.374 - 1.388

1.388 - 1.401

Technical analysis  (as of: 2018-12-17 4:25:04 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 4.74     One year: 6.68

Support:

Support1: 1.36    Support2: 1.13

Resistance:

Resistance1: 4.05    Resistance2: 5.72

Pivot:

3.00

Moving Averages:

MA(5): 1.53     MA(20): 3.41

MA(100): 4.47     MA(250): 4.66

MACD:

MACD(12,26): -0.91     Signal(12,26,9): -0.65

%K %D:

%K(14,3): 0.86     %D(3): 1.77

RSI:

RSI(14): 20.86

52-Week:

High: 7.95  Low: 1.3  Change(%): -68.3

Average Vol(K):

3-Month: 89355  10-Days 196694

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
CNAT has closed above bottom band by 23.2%. Bollinger Bands are 239.1% wider than normal. The large width of the bands suggest high volatility as compared to CNAT's normal range. The bands have been in this wide range for 7 bars. This is a sign that the current trend might continue.

Headline News

2018-12-17T15:06:56-05:00
Conatus' Failure Was A Blow, But The Most Important Study Is Yet To Come

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

33.14

Shares Float (M)

32.96

% Held by Insiders

% Held by Institutions

53.60

Shares Short (K)

Shares Short Prior Month (K)

Stock Financials

EPS

-0.620

EPS Est. Current Year

-0.530

EPS Est. Next Year

0.700

EPS Est. Next Quarter

-0.150

Forward EPS

0.130

Book Value (p.s.)

3.030

PEG Ratio

-0.07

Profit Margin

-51.99

Operating Margin

-53.40

Return on Assets (ttm)

-25.2

Return on Equity (ttm)

-77.6

Qtrly Rev. Growth

-19.9

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-36.23

Levered Free Cash Flow (M)

-22.53

Valuation

P/E

-2.24

P/E Growth Ratio

-0.09

P/BV

0.46

P/S

36259828.00

P/CF

-1.27

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.